![]() ; ; Okawa, Satoshi ![]() in Cell Death and Differentiation (2018) Detailed reference viewed: 211 (14 UL)![]() Hartmann, Andras ![]() ![]() ![]() in Scientific Reports (2018) Detailed reference viewed: 189 (49 UL)![]() Ashrafi, Amer ![]() ![]() in Neurobiology of Aging (2017), 58 Regulator of G-Protein Signaling 4 (RGS4), a member of the RGS family of proteins that inactivate G-proteins, has gained interest as a potential drug target for neurological disorders, such as epilepsy ... [more ▼] Regulator of G-Protein Signaling 4 (RGS4), a member of the RGS family of proteins that inactivate G-proteins, has gained interest as a potential drug target for neurological disorders, such as epilepsy and Parkinson’s disease (PD). In the case of PD, the main current option for alleviating motor symptoms are dopamine replacement therapies, which have limitations because of side effects, and reduced effectiveness over the long term. Research on new non-dopaminergic PD drug targets has indicated that inhibition of RGS4 could be an effective adjuvant treatment option. The effectiveness of RGS4 inhibition for an array of PD-linked functional and structural neuroprotection endpoints has not yet been demonstrated. Here, we use the 6-Hydroxydopamine (6-OHDA) lesioning model of the nigrostriatal pathway in mice to address this question. We observe, using a battery of behavioral and pathological measures, that mice deficient for RGS4 are not protected from 6-OHDA induced injury, and show enhanced susceptibility in some measures of motor function. Our results suggest that inhibition of RGS4 as a non-dopaminergic target for PD should be approached with caution. [less ▲] Detailed reference viewed: 271 (32 UL)![]() del Sol Mesa, Antonio ![]() in Genome Research (2017) Detailed reference viewed: 198 (7 UL)![]() del Sol Mesa, Antonio ![]() ![]() in Scientific Reports (2017) Detailed reference viewed: 192 (11 UL)![]() del Sol Mesa, Antonio ![]() in Neurobiology of Aging (2017) Detailed reference viewed: 106 (5 UL)![]() ![]() del Sol Mesa, Antonio ![]() in Neuroepigenomics in Aging and Disease (2017) Detailed reference viewed: 214 (6 UL)![]() del Sol Mesa, Antonio ![]() in PLoS Genetics (2017) Detailed reference viewed: 165 (5 UL)![]() del Sol Mesa, Antonio ![]() ![]() ![]() in Bioinformatics (2017) Detailed reference viewed: 237 (33 UL)![]() del Sol Mesa, Antonio ![]() in Cell Stem Cell (2017) Detailed reference viewed: 313 (28 UL)![]() Ravichandran, Srikanth ![]() ![]() in FEBS Letters (2017) Detailed reference viewed: 256 (18 UL)![]() ; ; Okawa, Satoshi ![]() in Frontiers in Immunology (2017) Detailed reference viewed: 132 (9 UL)![]() Ravichandran, Srikanth ![]() ![]() ![]() in Stem Cell Research (2016) Recent reports indicate a dominant role for cellular microenvironment or niche for stably maintaining cellular phenotypic states. Identification of key niche mediated signaling that maintains stem cells ... [more ▼] Recent reports indicate a dominant role for cellular microenvironment or niche for stably maintaining cellular phenotypic states. Identification of key niche mediated signaling that maintains stem cells in specific phenotypic states remains a challenge, mainly due to the complex and dynamic nature of stem cell-niche interactions. In order to overcome this, we consider that stem cells maintain their phenotypic state by experiencing a constant effect created by the niche by integrating its signals via signaling pathways. Such a constant niche effect should induce sustained activation/inhibition of specific stem cell signaling pathways that controls the gene regulatory program defining the cellular phenotypic state. Based on this view, we propose a computational approach to identify the most likely receptor mediated signaling responsible for transmitting niche signals to the transcriptional regulatory network that maintain cell-specific gene expression patterns, termed as niche determinants. We demonstrate the utility of our method in different stem cell systems by identifying several known and novel niche determinants. Given the key role of niche in several degenerative diseases, identification of niche determinants can aid in developing strategies for potential applications in regenerative medicine. [less ▲] Detailed reference viewed: 318 (43 UL)![]() Espinosa Angarica, Vladimir ![]() ![]() in BioEssays (2016), 38(8), Pluripotency can be considered a functional characteristic of pluripotent stem cells (PSCs) populations and their niches, rather than a property of individual cells. In this view, individual cells within ... [more ▼] Pluripotency can be considered a functional characteristic of pluripotent stem cells (PSCs) populations and their niches, rather than a property of individual cells. In this view, individual cells within the population independently adopt a variety of different expression states, maintained by different signaling, transcriptional, and epigenetics regulatory networks. In this review, we propose that generation of integrative network models from single cell data will be essential for getting a better understanding of the regulation of self-renewal and differentiation. In particular, we suggest that the identification of network stability determinants in these integrative models will provide important insights into the mechanisms mediating the transduction of signals from the niche, and how these signals can trigger differentiation. In this regard, the differential use of these stability determinants in subpopulation-specific regulatory networks would mediate differentiation into different cell fates. We suggest that this approach could offer a promising avenue for the development of novel strategies for increasing the efficiency and fidelity of differentiation, which could have a strong impact on regenerative medicine [less ▲] Detailed reference viewed: 239 (20 UL)![]() Antony, Paul ![]() ![]() ![]() in PLoS ONE (2016) Immunoresponsive gene 1 (IRG1) is one of the highest induced genes in macrophages under pro-inflammatory conditions. Its function has been recently described: it codes for immune-responsive gene 1 protein ... [more ▼] Immunoresponsive gene 1 (IRG1) is one of the highest induced genes in macrophages under pro-inflammatory conditions. Its function has been recently described: it codes for immune-responsive gene 1 protein/cis-aconitic acid decarboxylase (IRG1/CAD), an enzyme catalysing the production of itaconic acid from cis-aconitic acid, a tricarboxylic acid (TCA) cycle intermediate. Itaconic acid possesses specific antimicrobial properties inhibiting isocitrate lyase, the first enzyme of the glyoxylate shunt, an anaplerotic pathway that bypasses the TCA cycle and enables bacteria to survive on limited carbon conditions. To elucidate the mechanisms underlying itaconic acid production through IRG1 induction in macrophages, we examined the transcriptional regulation of IRG1. To this end, we studied IRG1 expression in human immune cells under different inflammatory stimuli, such as TNFα and IFNγ, in addition to lipopolysaccharides. Under these conditions, as previously shown in mouse macrophages, IRG1/CAD accumulates in mitochondria. Furthermore, using literature information and transcription factor prediction models, we re-constructed raw gene regulatory networks (GRNs) for IRG1 in mouse and human macrophages. We further implemented a contextualization algorithm that relies on genome-wide gene expression data to infer putative cell type-specific gene regulatory interactions in mouse and human macrophages, which allowed us to predict potential transcriptional regulators of IRG1. Among the computationally identified regulators, siRNA-mediated gene silencing of interferon regulatory factor 1 (IRF1) in macrophages significantly decreased the expression of IRG1/CAD at the gene and protein level, which correlated with a reduced production of itaconic acid. Using a synergistic approach of both computational and experimental methods, we here shed more light on the transcriptional machinery of IRG1 expression and could pave the way to therapeutic approaches targeting itaconic acid levels. [less ▲] Detailed reference viewed: 298 (17 UL)![]() del Sol Mesa, Antonio ![]() ![]() ![]() in Cell Death and Disease (2016), 7 Detailed reference viewed: 423 (48 UL)![]() ; Buttini, Manuel ![]() ![]() in Movement Disorders (2016), 31(2), 630 Detailed reference viewed: 70 (3 UL)![]() Okawa, Satoshi ![]() ![]() ![]() in Stem Cell Reports (2016) Detailed reference viewed: 483 (104 UL)![]() ; ; et al in Stem Cells (2016) Detailed reference viewed: 308 (10 UL)![]() Okawa, Satoshi ![]() ![]() in Stem Cell Research (2015) Detailed reference viewed: 260 (47 UL) |
||